Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Icon Group Expands Cancer Care Capabilities with Purchase of Varian Adaptive Therapy Solution 2019-10-31 04:05
GC Pharma Reports Q3 2019 Results 2019-10-30 21:00
New NCCN Guidelines Debut to Manage Complications and Improve Readiness for Stem Cell Transplant Recipients 2019-10-30 20:30
Seneca Biopharma and QYuns Therapeutics Sign Term Sheet for Global Licensing of Novel Monoclonal Antibodies for Treating Auto-Immune Diseases 2019-10-30 19:00
EC Approves Astellas' XOSPATA(TM) for Patients with Relapsed or Refractory Acute Myeloid Leukemia with Mutations Detected using Invivoscribe's LeukoStrat(R) CDx FLT3 Mutation Assay 2019-10-30 18:00
AI Medical Technology Enters "One Belt, One Road" Initiative; Ping An Good Doctor Attends 3rd Future Investment Initiative 2019-10-30 13:57
World Pancreatic Cancer Day Campaign Launches to Raise Awareness of the Risks and Symptoms of the World's Toughest Cancer 2019-10-30 05:47
NeoDynamics Receives Regulatory Approval for new Breast Cancer Biopsy System 2019-10-30 00:13
Effect of Climate Change on the Brain, Link to Alzheimer's and Parkinson's, to be Key Focus of Discussion at XXIV World Congress of Neurology 2019-10-29 21:53
WAT Medical will be returning to 2019 MEDICA to exhibit their innovative wearable technologies 2019-10-29 21:00
New Study in Hong Kong Shows Home Ambulatory Chemotherapy Improves Cancer Patient's Quality of Life 2019-10-29 16:52
Amaris B. Clinic Reveals Health Benefits of VASER Liposuction 2019-10-29 14:43
Seneca Biopharma to Present at the 7th China Renaissance Healthcare and Life Sciences Leadership Summit 2019-10-29 13:17
European Commission Approves BAVENCIO® (avelumab) Plus Axitinib Combination for First-Line Treatment of Patients With Advanced Renal Cell Carcinoma 2019-10-29 02:00
Arena Pharmaceuticals Announces First Subject Dosed in ADVISE Phase 2 Trial Evaluating Etrasimod in Atopic Dermatitis 2019-10-28 20:30
HistoIndex Announces Global Partnerships To Expand AI-Based Digital Pathology Platform As A Drug Discovery Tool In Preclinical Studies For Nonalcoholic Steatohepatitis (NASH) 2019-10-28 08:38
WuXi STA's Jinshan Facility Passes EMA Inspection 2019-10-28 08:00
HistoIndex Announces Global Partnerships To Expand AI-Based Digital Pathology Platform As A Drug Discovery Tool In Preclinical Studies For Nonalcoholic Steatohepatitis (NASH) 2019-10-26 19:00
Adagene Presents Its Lead Antibody Program, ADG106, at International Conferences 2019-10-26 18:01
VISEN Pharmaceuticals announces China Phase 3 clinical study initiation for TransCon human growth hormone, the first unmodified long-acting growth hormone in China 2019-10-26 09:00
1 605 606 607 608 609 953